Immune thrombocytopenia (ITP): vizsgálatok itt: Kína

In Kína 67 Also abroad 118

67 trials · From ClinicalTrials.gov, checked 2026. november 13.. Ask the study team whether a trial fits you.

1/2. fázisTaking people
A Phase 1/2 Study of ESG206 in Patients With Primary Immune Thrombocytopenia
Where
Jinan
Életkor
18 év and over
People
84
Run by
Shanghai Escugen Biotechnology Co., Ltd
See details and how to joinNCT06853444
Korai 1. fázisTaking people
An Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Primary Immune Thrombocytopenia
Where
Changzhou
Életkor
18 év to 65 év
People
9
Run by
Changzhou No.2 People's Hospital
See details and how to joinNCT06337474
2/3. fázisNot yet taking people in Kína
The Study of Different Cycles of High-dose Dexamethasone in the Treatment of ITP
Where
Jinan
Életkor
18 év and over
People
118
Run by
Shandong University
See details and how to joinNCT06913374
2. fázisTaking people
An Open, Exploratory Clinical Study of CM336 in the Treatment of Immune Thrombocytopenia
Where
Tianjin
Életkor
18 év and over
People
20
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06799611
2. fázisTaking people
A Clinical Study on the Efficacy and Safety of Herombopag in the Treatment of Senile Primary ITP
Where
Tianjin
Életkor
60 év and over
People
80
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06838949
No phaseNot yet taking people in Kína
Validation of the EQ-5D-Y-3L and EQ-5D-Y-5L for Paediatric Patients in China
Where
Guiyang
Életkor
5 év to 16 év
People
360
Run by
RenJi Hospital
See details and how to joinNCT06873672
2. fázisTaking people
Avatrombopag in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies
Where
Tianjin
Életkor
18 év and over
People
52
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT04993885
2. fázisTaking people
A Prospective, One-arm and Open Clinical Study of Zanubrutinib in the Treatment of Immune Thrombocytopenia
Where
Tianjin
Életkor
18 év and over
People
30
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT05214391
2. fázisTaking people
A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Pediatric Primary Immune Thrombocytopenia (ITP)
Where
Tianjin
Életkor
12 év to 18 év
People
60
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06094881
2. fázisTaking people
Avatrombopag in the Treatment of Pediatric Immune Thrombocytopenia
Where
Tianjin
Életkor
6 év to 18 év
People
60
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06281327
1. fázisTaking people
BCMA-CD19 CCAR T Cell Treatment of Refractory Immune Thrombocytopenia Associated with Autoimmune Diseases
Where
Chengdu
Életkor
18 év to 60 év
People
20
Run by
iCell Gene Therapeutics
See details and how to joinNCT06787989
No phaseTaking people
Longitudinal Cohort of Thrombosis and Hemostasis Diseases
Where
Beijing, Chongqing, Zhengzhou
People
3000
Run by
Peking University People's Hospital
See details and how to joinNCT06727669
1/2. fázisTaking people
Efficacy and Safety of CAR-T Cells Therapy for Chronic or Refractory Primary Immune Thrombocytopenia (ITP)
Where
Kunming
Életkor
8 év to 75 év
People
10
Run by
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
See details and how to joinNCT06352281
No phaseTaking people
The Efficacy and Safety of HCQ Plus TPO-RA in ANA Positive ITP
Where
Shanghai
Életkor
15 év to 99 év
People
126 worldwide
Run by
Yunfeng Cheng
See details and how to joinNCT06479291
No phaseTaking people
The Efficacy and Safety of HCQ Plus Pred in ANA Positive ITP
Where
Shanghai
Életkor
15 év to 99 év
People
129 worldwide
Run by
Yunfeng Cheng
See details and how to joinNCT06479304
No phaseTaking people
The Efficacy and Safety of HCQ Plus DEX in ANA Positive ITP
Where
Shanghai
Életkor
15 év to 75 év
People
129 worldwide
Run by
Yunfeng Cheng
See details and how to joinNCT06479317
2. fázisTaking people
TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment Termination
Where
Beijing
Életkor
18 év to 50 év
People
56
Run by
Peking Union Medical College Hospital
See details and how to joinNCT06478537